Clinical Trials Browser

Observational × Breast Neoplasms × trastuzumab deruxtecan × Clear all

NCT06551220 2026-05-22

HEROIC

Breast Neoplasms

NCT06663787 2026-05-13

HER2 CR

Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT07582887 2026-05-13

Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05945732 2026-02-12

DESTINY Breast Respond HER2-low Europe

Breast Neoplasms

NCT06210776 2026-01-12

A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)

Breast Neoplasms

NCT06386263 2025-10-15

HER-TEMPO

Breast Neoplasms

NCT06504719 2025-09-15

Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT06727227 2025-07-01

EXPLORE

Breast Neoplasms

NCT07030569 2025-06-22

RADIOSPHER2

Breast Neoplasms

NCT06231693 2025-05-08

Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil

Breast Neoplasms

NCT06135194 2023-11-18

Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib

Breast Neoplasms

NCT05594082 2023-04-04

Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer

Breast Neoplasms